{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-205589","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.659082+00:00","generated_at":"2026-06-12T03:18:28.684636+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"XOMA Q2 net loss $5.4M; revenue $1.7M, cash $31.4M; two royalty deals in H1","bullets":["Total revenue $1.7M (Q2 2022: $1.0M), driven by $1.1M milestone from Janssen license.","Net loss $5.4M vs $4.7M in Q2 2022; includes $1.6M non-cash impairment on Bioasis royalty.","Cash and equivalents $31.4M at June 30, 2023, down from $57.8M at Dec 31, 2022.","Net cash used in operations $7.2M, including $4.1M one-time arbitration settlement cost.","Expects lower milestone receipts in 2023 due to partner delays; cash sufficient for multiple years."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-205589","json":"https://secwatch.observer/filing/0001193125-23-205589.json","markdown":"https://secwatch.observer/filing/0001193125-23-205589.md","text":"https://secwatch.observer/filing/0001193125-23-205589.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312523205589/0001193125-23-205589-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312523205589/d476330d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T03:18:28.684636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38c64b6131066586f8e00d5cbed5307e3a010716","claim":"XOMA Royalty Corp reported the quarter ended June 30, 2023 results: revenue total revenues of $1.7 million, net income Net loss for the second quarter of 2023 was $5.4 million.","evidence_excerpt":"XOMA recorded total revenues of $1.7 million for the second quarter of 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523205589/0001193125-23-205589-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended June 30, 2023"},{"label":"Revenue","value":"total revenues of $1.7 million"},{"label":"Net income","value":"Net loss for the second quarter of 2023 was $5.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}